Varenicline-d4 Hydrochloride (Major)
ACCÈS RAPIDE AUX LIENS
Varenicline-13C2,15N2 Tartrate is a chemical compound that acts as a partial agonist at the α4β2 subtype of the nicotinic acetylcholine receptor. It functions by binding to the receptor and stimulating it to a lesser extent than nicotine, thereby reducing the rewarding effects of smoking. Varenicline-13c2,15n2 Tartrate's mechanism of action involves competing with nicotine for binding sites on the receptor, ultimately leading to a decrease in the release of dopamine in the brain's reward pathway. By modulating the activity of the nicotinic acetylcholine receptor, Varenicline-13C2,15N2 Tartrate helps to alleviate nicotine withdrawal symptoms and reduce the reinforcing effects of smoking. Varenicline-13c2,15n2 Tartrate's functional role in research and development lies in its ability to elucidate the molecular mechanisms underlying nicotine addiction and aid in the development of novel therapeutic strategies for smoking cessation.
Informations pour la commande
| Nom du produit | Ref. Catalogue | COND. | Prix HT | QTÉ | Favoris | |
Varenicline-d4 Hydrochloride (Major), 2.5 mg | sc-220370 | 2.5 mg | $393.00 |